BioSpace News Archive

Business

The State of Louisiana Pharmacy Board Has Selected Nine Initial Pharmacies to Dispense Medical Cannabis Formulations Through the GB Sciences and LSU Agriculture Center Partnership

In Partnership with GB Sciences and LSU AgCenter, Nine Select Louisiana Pharmacies Are Set to Pioneer the Louisiana Medical Cannabis Program.

August 23, 2018
·
5 min read
Pharm Country

West Announces Participation in Upcoming September 2018 Investor Conferences

West Pharmaceutical Services, Inc. announced that its Management Team will present an overview of the Company’s business at three investor conferences in September.

August 23, 2018
·
1 min read
Bio NC

Marken Launches New Website Highlighting Clinical Supply Chain Solutions

Website Reinforces Marken’s Leading Position within Industry

August 23, 2018
·
2 min read
Business

ConsumerMedical Announces Executive Leadership Promotions in Support of Growth

ConsumerMedical has announced executive leadership promotions, including the advancement of Kevin Kickhaefer to the newly-created position of President, and Manny Menendez to the position of Chief Revenue Officer.

August 23, 2018
·
4 min read
Pharm Country

MedRisk Makes the Inc. 5000 List for 12th Year

The leading workers’ compensation managed care company is one of the nation’s fastest growing, private companies

August 23, 2018
·
2 min read
Business

ApoGen Biotechnologies Expands Series A Financing to $11 Million and Enhances Leadership Team

M Ventures Joins Existing Investors to Support Development of Novel Therapies Targeting Resistance to Cancer Therapy

August 23, 2018
·
6 min read
Business

bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies

bluebird bio, Inc. and Gritstone Oncology, Inc. today announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy.

August 23, 2018
·
6 min read
Policy

Eisai and Merck Announce European Commission Grants Marketing Authorization for LENVIMA® (lenvatinib) as First-Line Treatment in Adults with Advanced or Unresectable Hepatocellular Carcinoma

First new, first-line treatment option for advanced or unresectable HCC approved in Europe in a decade

August 23, 2018
·
23 min read
Drug Development

Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy

Drug to be studied for improved functional outcomes and survival rates for patients resuscitated after a cardiac arrest

August 23, 2018
·
6 min read
FDA

Roche receives FDA approval for cobas EGFR Mutation Test v2 as companion diagnostic with IRESSA (gefitinib) in first-line treatment of patients with non-small cell lung cancer (NSCLC)

New indication approval for cobas EGFR Mutation Test v2 as companion diagnostic, follows previous approvals with Tarceva (erlotinib) and TAGRISSO (osimertinib)

August 23, 2018
·
4 min read